Talis Biomedical Corporation operates as a molecular diagnostic company.

The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases.

It also develops Talis One tests for respiratory infections, infections related to women's health, and sexually transmitted infections; and other tests for the detection of other respiratory infections, such as a respiratory panel test to detect influenza A and influenza B.

The company was incorporated in 2013 and is headquartered in Redwood, California.